Is Tilray Stock a Buy on Positive Cannabis Data?

Date:

Cannabis stocks are in focus today, with most of the action centered around U.S.-based multi-state operators (MSOs) after reports suggested that President-elect Donald Trump may look to deschedule marijuana as part of a broader deregulation agenda. 

Tilray Brands (TLRY) also closed higher, with the global distributor and medical cannabis pioneer rising more than 5% on the day.

About Tilray Brands Stock

Valued at $1.26 billion by market cap and listed in both New York and Toronto, Tilray Brands (TLRY) is a lifestyle consumer goods company that focuses on the research, production, cultivation, and distribution of medical and recreational cannabis-related products. It operates through four different segments: Cannabis, Beverage Alcohol, Wellness, and Distribution. It markets its products under the brands Shock Top, Aphria, CC Pharma, Breckenridge Distillery, and many more. 

TLRY has global reach, primarily as a medical and recreational…

Read more…

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

Tampa RV giant Lazydays to delist from Nasdaq

Tampa-based Lazydays Holdings Inc., one of Florida’s most recognized...

Granite Geek: New Hampshire might get access to ‘balcony solar’

I had solar panels put on my roof six...

TSX Today: What to Watch for in Stocks on Monday, November 10

Despite firm gold and silver prices, Canadian stocks...

While BNB and DOT Struggle Under Market Pressure, BlockDAG’s Presale Soars Past $435M!

As market-wide fear grips the sector, the Binance Coin...